iBio (IBIO) FCF Margin (QoQ) (2011 - 2025)
iBio (IBIO) FCF Margin (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.58 Bn | 466.79 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.80 Bn | 50.61 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.37 Bn | 34.36 Bn | 959.66 Mn |
| 10 | iBio | 166.24 Mn | 166.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -339,650.00 |
| Sep 30, 2021 | -1.05 Mn |
| Jun 30, 2021 | -89,325.00 |
| Mar 31, 2021 | 24,472.00 |
| Dec 31, 2020 | 49,141.00 |
| Sep 30, 2020 | -140,926.00 |
| Jun 30, 2020 | 359,830.00 |
| Mar 31, 2020 | -286,690.00 |
| Dec 31, 2019 | 96,887.00 |
| Sep 30, 2019 | -154,703.00 |
| Jun 30, 2019 | 23,835.00 |
| Mar 31, 2019 | -3,411.00 |
| Dec 31, 2018 | 156,297.00 |
| Sep 30, 2018 | 161,497.00 |
| Jun 30, 2018 | 109,212.00 |
| Mar 31, 2018 | -258,147.00 |
| Dec 31, 2017 | 8,824.00 |
| Sep 30, 2017 | 35,925.00 |
| Jun 30, 2017 | 744,317.00 |
| Mar 31, 2017 | -541,672.00 |